Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq Other stock markets 16:00:00 2026-02-13 EST			5-day change	1st Jan Change
42.23 ^USD	+5.29%		+2.97%	+43.20%

02-13	Health Care Up Amid Mixed Earnings - Health Care Roundup	DJ
02-13	Equities Mixed After CPI Data; Wall Street Sees Worst Week Since November	MT

Transcript : Moderna, Inc. - Special Call

Published on 06/16/2025 at 12:05 pm EDT - Modified on 06/16/2025 at 04:50 pm EDT

S&P Capital IQ

Presenter Speech
Huidong Wang (Analysts)

My name is Gena Wang. I'm SMID Cap biotech analyst at the Barclays. Thank you for joining our call today. We are very pleased to continue our 8th annual

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Moderna, Inc.

02-13	Health Care Up Amid Mixed Earnings - Health Care Roundup	DJ
02-13	Equities Mixed After CPI Data; Wall Street Sees Worst Week Since November	MT
02-13	Sector Update: Health Care Stocks Advance Late Afternoon	MT
02-13	Wall St indexes rises as tech steadies, inflation cools	RE
02-13	Equities Rise Intraday as Markets Parse CPI Report	MT
02-13	Sector Update: Health Care Stocks Higher Friday Afternoon	MT
02-13	Sector Update: Health Care	MT
02-13	RBC Raises Price Target on Moderna to $30 From $25, Keeps Sector Perform Rating	MT
02-13	Jefferies Raises Price Target on Moderna to $37 From $30	MT
02-13	Moderna, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-13	Moderna Maintains Full-Year Revenue Growth Outlook Following Fourth-Quarter Beat	MT
02-13	Moderna, Inc., Q4 2025 Earnings Call, Feb 13, 2026
02-13	Moderna Shares Rise After Q4 Loss Narrows, Revenue Beats Estimates	MT
02-13	Sector Update: Health Care Stocks Edge Higher Premarket Friday	MT
02-13	Moderna Reiterates 10% Revenue-Growth Target as Covid Vaccine Demand Falls -- Update	DJ